Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Receivables - Net (2020 - 2025)

Historic Receivables - Net for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $18.0 million.

  • Journey Medical's Receivables - Net rose 6852.22% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year increase of 6852.22%. This contributed to the annual value of $10.2 million for FY2024, which is 3278.81% down from last year.
  • Latest data reveals that Journey Medical reported Receivables - Net of $18.0 million as of Q3 2025, which was up 6852.22% from $15.6 million recorded in Q2 2025.
  • Journey Medical's Receivables - Net's 5-year high stood at $31.7 million during Q3 2021, with a 5-year trough of $8.0 million in Q3 2023.
  • Moreover, its 5-year median value for Receivables - Net was $18.0 million (2025), whereas its average is $19.5 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first tumbled by 7200.08% in 2023, then soared by 8394.73% in 2025.
  • Quarter analysis of 5 years shows Journey Medical's Receivables - Net stood at $23.1 million in 2021, then increased by 22.05% to $28.2 million in 2022, then tumbled by 46.04% to $15.2 million in 2023, then plummeted by 32.79% to $10.2 million in 2024, then skyrocketed by 75.77% to $18.0 million in 2025.
  • Its Receivables - Net was $18.0 million in Q3 2025, compared to $15.6 million in Q2 2025 and $18.0 million in Q1 2025.